_id
690f39eaccc777a4e85d190c
Ticker
BWAY
Name
Brainsway Ltd
Exchange
NASDAQ
Address
16 Hartum St, Jerusalem, Israel, 9777516
Country
USA
Sector
Healthcare
Industry
Medical Devices
Currency
USD
Website
https://www.brainsway.com
Description
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.
Last Close
17.353
Volume
148702
Current Price
17.2105
Change
-0.8211836570045631
Last Updated
2025-11-29T11:02:25.719Z
Image
data:image/webp;base64,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
Ipo Date
1999-10-06T00:00:00.000Z
Market Cap
342176672
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.1855
Sentiment Sources
6
Rating
4.75
Target Price
18.75
Strong Buy
3
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
13512000
Cost Of Revenue
3353000
Gross Profit
10159000
Operating Expenses
8906000
Operating Income
1253000
Interest Expense
571000
Pretax Income
1808000
Net Income
1566000
Eps
0.08240526551755348
Dividends Per Share
-
Shares Outstanding
19564131
Income Tax Expense
242000
EBITDA
2212000
Operating Margin
9.273238602723504
Total Other Income Expense Net
555000
Cash
70458000
Short Term Investments
1079000
Receivables
5129000
Inventories
4418000
Total Current Assets
82933000
Property Plant Equipment
14017000
Total Assets
113062000
Payables
2791000
Short Term Debt
1042999
Long Term Debt
-
Total Liabilities
42997000
Equity
70065000
Depreciation
404000
Change In Working Capital
-827000
Cash From Operations
1386000
Capital Expenditures
800000
Cash From Investing
1365000
Cash From Financing
-208000
Net Change In Cash
2546000
PE
54.6563
PB
4.667981820024263
ROE
2.2350674373795765
ROA
1.3850807521536854
FCF
586000
Fcf Percent
0.04336885731201895
Piotroski FScore
3
Health Score
47
Deep Value Investing Score
5.5
Defensive Investing Score
6.5
Dividend Investing Score
3
Economic Moat Investing Score
7.3
Garp Investing Score
4
Growth Investing Score
3.5
Momentum Investing Score
5
Net Net Investing Score
4
Quality Investing Score
5.5
Value Investing Score
3.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
13512000
Quarters > 0 > income Statement > cost Of Revenue
3353000
Quarters > 0 > income Statement > gross Profit
10159000
Quarters > 0 > income Statement > operating Expenses
8906000
Quarters > 0 > income Statement > operating Income
1253000
Quarters > 0 > income Statement > interest Expense
571000
Quarters > 0 > income Statement > pretax Income
1808000
Quarters > 0 > income Statement > net Income
1566000
Quarters > 0 > income Statement > eps
0.08240526551755348
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
19003640
Quarters > 0 > income Statement > income Tax Expense
242000
Quarters > 0 > income Statement > EBITDA
2212000
Quarters > 0 > income Statement > operating Margin
9.273238602723504
Quarters > 0 > income Statement > total Other Income Expense Net
555000
Quarters > 0 > balance Sheet > cash
70458000
Quarters > 0 > balance Sheet > short Term Investments
1079000
Quarters > 0 > balance Sheet > receivables
5129000
Quarters > 0 > balance Sheet > inventories
4418000
Quarters > 0 > balance Sheet > total Current Assets
82933000
Quarters > 0 > balance Sheet > property Plant Equipment
14017000
Quarters > 0 > balance Sheet > total Assets
113062000
Quarters > 0 > balance Sheet > payables
2791000
Quarters > 0 > balance Sheet > short Term Debt
1042999
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
42997000
Quarters > 0 > balance Sheet > equity
70065000
Quarters > 0 > cash Flow > net Income
1566000
Quarters > 0 > cash Flow > depreciation
404000
Quarters > 0 > cash Flow > change In Working Capital
-827000
Quarters > 0 > cash Flow > cash From Operations
1386000
Quarters > 0 > cash Flow > capital Expenditures
800000
Quarters > 0 > cash Flow > cash From Investing
1365000
Quarters > 0 > cash Flow > cash From Financing
-208000
Quarters > 0 > cash Flow > net Change In Cash
2546000
Quarters > 0 > ratios > PE
0.08240526551755348
Quarters > 0 > ratios > PB
4.667981820024263
Quarters > 0 > ratios > ROE
2.2350674373795765
Quarters > 0 > ratios > ROA
1.3850807521536854
Quarters > 0 > ratios > FCF
586000
Quarters > 0 > ratios > Piotroski FScore
3
Quarters > 0 > ratios > fcf Percent
0.04336885731201895
Quarters > 0 > health Score
47
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
12632000
Quarters > 1 > income Statement > cost Of Revenue
3133000
Quarters > 1 > income Statement > gross Profit
9499000
Quarters > 1 > income Statement > operating Expenses
8921000
Quarters > 1 > income Statement > operating Income
578000
Quarters > 1 > income Statement > interest Expense
784000
Quarters > 1 > income Statement > pretax Income
2097000
Quarters > 1 > income Statement > net Income
2027000
Quarters > 1 > income Statement > eps
0.10727783525077689
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
18894863
Quarters > 1 > income Statement > income Tax Expense
70000
Quarters > 1 > income Statement > EBITDA
3269000
Quarters > 1 > income Statement > operating Margin
4.575680810639645
Quarters > 1 > income Statement > total Other Income Expense Net
1519000
Quarters > 1 > balance Sheet > cash
67912000
Quarters > 1 > balance Sheet > short Term Investments
10087000
Quarters > 1 > balance Sheet > receivables
3871000
Quarters > 1 > balance Sheet > inventories
4190000
Quarters > 1 > balance Sheet > total Current Assets
89490000
Quarters > 1 > balance Sheet > property Plant Equipment
13174000
Quarters > 1 > balance Sheet > total Assets
111564000
Quarters > 1 > balance Sheet > payables
1209000
Quarters > 1 > balance Sheet > short Term Debt
911000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
43432000
Quarters > 1 > balance Sheet > equity
68132000
Quarters > 1 > cash Flow > net Income
2027000
Quarters > 1 > cash Flow > depreciation
388000
Quarters > 1 > cash Flow > change In Working Capital
10991000
Quarters > 1 > cash Flow > cash From Operations
12383000
Quarters > 1 > cash Flow > capital Expenditures
1166000
Quarters > 1 > cash Flow > cash From Investing
-15859000
Quarters > 1 > cash Flow > cash From Financing
-264000
Quarters > 1 > cash Flow > net Change In Cash
-3689000
Quarters > 1 > ratios > PE
0.10727783525077689
Quarters > 1 > ratios > PB
4.772941344177479
Quarters > 1 > ratios > ROE
2.975107144953913
Quarters > 1 > ratios > ROA
1.8168943386755585
Quarters > 1 > ratios > FCF
11217000
Quarters > 1 > ratios > Piotroski FScore
4
Quarters > 1 > ratios > fcf Percent
0.887982900569981
Quarters > 1 > health Score
64
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
11536000
Quarters > 2 > income Statement > cost Of Revenue
2926000
Quarters > 2 > income Statement > gross Profit
8610000
Quarters > 2 > income Statement > operating Expenses
8034000
Quarters > 2 > income Statement > operating Income
576000
Quarters > 2 > income Statement > interest Expense
586000
Quarters > 2 > income Statement > pretax Income
1264000
Quarters > 2 > income Statement > net Income
1107000
Quarters > 2 > income Statement > eps
0.06
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
18450000
Quarters > 2 > income Statement > income Tax Expense
157000
Quarters > 2 > income Statement > EBITDA
2244000
Quarters > 2 > income Statement > operating Margin
4.993065187239944
Quarters > 2 > income Statement > total Other Income Expense Net
688000
Quarters > 2 > balance Sheet > cash
71601000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
6954000
Quarters > 2 > balance Sheet > inventories
4680000
Quarters > 2 > balance Sheet > total Current Assets
84656000
Quarters > 2 > balance Sheet > property Plant Equipment
12240000
Quarters > 2 > balance Sheet > total Assets
100198000
Quarters > 2 > balance Sheet > payables
2104000
Quarters > 2 > balance Sheet > short Term Debt
818000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
36448000
Quarters > 2 > balance Sheet > equity
63750000
Quarters > 2 > cash Flow > net Income
1107000
Quarters > 2 > cash Flow > depreciation
394000
Quarters > 2 > cash Flow > change In Working Capital
2688000
Quarters > 2 > cash Flow > cash From Operations
5010000
Quarters > 2 > cash Flow > capital Expenditures
1043000
Quarters > 2 > cash Flow > cash From Investing
-1966000
Quarters > 2 > cash Flow > cash From Financing
-755000
Quarters > 2 > cash Flow > net Change In Cash
2256000
Quarters > 2 > ratios > PE
0.06
Quarters > 2 > ratios > PB
4.980921176470589
Quarters > 2 > ratios > ROE
1.7364705882352942
Quarters > 2 > ratios > ROA
1.1048124713068126
Quarters > 2 > ratios > FCF
3967000
Quarters > 2 > ratios > Piotroski FScore
4
Quarters > 2 > ratios > fcf Percent
0.343880027739251
Quarters > 2 > health Score
63
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
11414000
Quarters > 3 > income Statement > cost Of Revenue
2903000
Quarters > 3 > income Statement > gross Profit
8511000
Quarters > 3 > income Statement > operating Expenses
8080000
Quarters > 3 > income Statement > operating Income
431000
Quarters > 3 > income Statement > interest Expense
1055000
Quarters > 3 > income Statement > pretax Income
1736000
Quarters > 3 > income Statement > net Income
1548000
Quarters > 3 > income Statement > eps
0.04
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
38700000
Quarters > 3 > income Statement > income Tax Expense
188000
Quarters > 3 > income Statement > EBITDA
1067000
Quarters > 3 > income Statement > operating Margin
3.776064482214824
Quarters > 3 > income Statement > total Other Income Expense Net
1305000
Quarters > 3 > balance Sheet > cash
69345000
Quarters > 3 > balance Sheet > short Term Investments
0
Quarters > 3 > balance Sheet > receivables
4596000
Quarters > 3 > balance Sheet > inventories
4426000
Quarters > 3 > balance Sheet > total Current Assets
79527000
Quarters > 3 > balance Sheet > property Plant Equipment
11873000
Quarters > 3 > balance Sheet > total Assets
93987000
Quarters > 3 > balance Sheet > payables
2772000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
31674000
Quarters > 3 > balance Sheet > equity
62313000
Quarters > 3 > cash Flow > net Income
1548000
Quarters > 3 > cash Flow > depreciation
636000
Quarters > 3 > cash Flow > change In Working Capital
267000
Quarters > 3 > cash Flow > cash From Operations
3426000
Quarters > 3 > cash Flow > capital Expenditures
851000
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
19585000
Quarters > 3 > cash Flow > net Change In Cash
21218000
Quarters > 3 > ratios > PE
0.04
Quarters > 3 > ratios > PB
10.688722256992923
Quarters > 3 > ratios > ROE
2.4842328246112366
Quarters > 3 > ratios > ROA
1.6470362922531838
Quarters > 3 > ratios > FCF
2575000
Quarters > 3 > ratios > Piotroski FScore
4
Quarters > 3 > ratios > fcf Percent
0.22560014017872787
Quarters > 3 > health Score
61
Valuation > metrics > PE
54.6563
Valuation > metrics > PB
4.667981820024263
Valuation > final Score
3.3201817997573713
Valuation > verdict
87.1% Overvalued
Profitability > metrics > ROE
2.2350674373795765
Profitability > metrics > ROA
1.8882712551095464
Profitability > metrics > Net Margin
0.11589698046181172
Profitability > final Score
28
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.613673017911939
Risk > metrics > Interest Coverage
2.1943957968476355
Risk > final Score
57
Risk > verdict
High
Liquidity > metrics > Current Ratio
21.63093939252462
Liquidity > metrics > Quick Ratio
20.47861775655132
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
52.27058655822521
Prev Valuations > 1
50.190788235294114
Prev Valuations > 2
40
Prev Profitabilities > 0
37
Prev Profitabilities > 1
22
Prev Profitabilities > 2
31
Prev Risks > 0
51
Prev Risks > 1
52
Prev Risks > 2
50
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-13T00:30:05.772Z
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AShowing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$18.75
Analyst Picks
Strong Buy
3
Buy
1
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Neutral
(Last Updated 2025-09-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very Low
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Medium
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 29.11% of the total shares of Brainsway Ltd
1.
Valor Management LLC(11.1299%)
since
2025/06/30
2.
Masters Capital Management LLC(5.2905%)
since
2025/06/30
3.
Phoenix Financial Ltd(1.9168%)
since
2025/06/30
4.
Essex Investment Management Company, LLC(1.5921%)
since
2025/06/30
5.
Renaissance Technologies Corp(1.5018%)
since
2025/06/30
6.
ARK Investment Management LLC(1.0572%)
since
2025/06/30
7.
Cresset Asset Management, LLC(0.8331%)
since
2025/06/30
8.
Dafna Capital Management LLC(0.6727%)
since
2025/06/30
9.
MYDA Advisors LLC(0.5333%)
since
2025/06/30
10.
Two Sigma Advisers, LLC(0.4783%)
since
2025/06/30
11.
Legato Capital Management LLC(0.4713%)
since
2025/06/30
12.
Two Sigma Investments LLC(0.4349%)
since
2025/06/30
13.
Huntleigh Advisors Inc(0.4096%)
since
2025/06/30
14.
1290 Essex Small Cap Growth I(0.3475%)
since
2025/07/31
15.
Eagle Global Advisors, LLC(0.3297%)
since
2025/06/30
16.
Timothy Plan Israel Common Values A(0.3297%)
since
2025/06/30
17.
Citadel Advisors Llc(0.3222%)
since
2025/06/30
18.
Marshall Wace Asset Management Ltd(0.2718%)
since
2025/06/30
19.
Pleiades Small Cap Equity A(0.2194%)
since
2025/06/30
20.
Zuckerman Investment Group, LLC(0.201%)
since
2025/06/30
21.
Morgan Stanley - Brokerage Accounts(0.1607%)
since
2025/06/30
22.
Good Life Advisors, LLC(0.145%)
since
2025/06/30
23.
Goss Wealth Management LLC(0.1411%)
since
2025/06/30
24.
ActivePassive International Equity ETF(0.1064%)
since
2025/08/29
25.
Mandarine Global Microcap G EUR(0.0422%)
since
2025/05/31
26.
Acadian Global Small-Cap Equity CIT Cl A(0.0363%)
since
2025/03/04
27.
Essex Inv Mgt Micro Cap Growth(0.0361%)
since
2025/03/31
28.
Fidelity Nasdaq Composite Index(0.0265%)
since
2025/07/31
29.
Voya Multi-Manager International Sm Cp A(0.026%)
since
2025/06/30
30.
Acadian All Ctry Wld ex US SCap Eq CL A(0.0228%)
since
2025/03/04
31.
Essex Small Growth(0.0063%)
since
2025/03/31
32.
Dimensional Gl Cor Eq LC ESG Sc USD A(0.0063%)
since
2025/07/31
33.
Dimensional VA International Small Port(0.0053%)
since
2025/07/31
34.
Blackstone Alternative Multi-Strategy I(0.0016%)
since
2024/12/31
35.
Man Balanced Managed Retail Acc A(0.0001%)
since
2025/02/28
36.
UWS GLG Stockmarket Managed B(0.0001%)
since
2025/02/28
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.